RecruitingNCT06557460
A Phase IIb Randomized, Multicenter Trial of Subretinal CPCB-RPE1 in Advanced Dry AMD (Geographic Atrophy)
PHASE2 · 24 planned enrolment
- Countries listed
- 1
- Registry update
- September 23, 2026
immortal.lifePublic trial registrations naming Regenerative Patch Technologies, LLC as an industry lead sponsor.
This is an independent registry-name view, not a verified corporate profile, portfolio valuation, ownership map, endorsement, or investment recommendation.
This does not mean that no transaction exists. A record appears only after its disclosure source and the connection to this exact registry sponsor identity are separately verified.
PHASE2 · 24 planned enrolment